{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:15:45Z","timestamp":1789402545872,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09915-8","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T12:01:52Z","timestamp":1726747312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The potential of circulating microRNAs as novel diagnostic biomarkers of COVID-19: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Melaku Ashagrie","family":"Belete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denekew Tenaw","family":"Anley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sintayehu Simie","family":"Tsega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natnael","family":"Moges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel Mulatie","family":"Anteneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melkamu Aderajew","family":"Zemene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaye Alamneh","family":"Gebeyehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anteneh Mengist","family":"Dessie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natnael","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias Sisay","family":"Chanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermiyas","family":"Alemayehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"issue":"9","key":"9915_CR1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/17476348.2020.1778470","volume":"14","author":"C Robba","year":"2020","unstructured":"Robba C, Battaglini D, Pelosi P, Rocco PR. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med. 2020;14(9):865\u20138.","journal-title":"Expert Rev Respir Med"},{"issue":"10223","key":"9915_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"key":"9915_CR3","unstructured":"World Health Organization. Coronavirus (COVID\u201319) Dashboard. [Internet]. 2024 [cited 16 January 2024]. https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=c"},{"issue":"5","key":"9915_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ddr.21666","volume":"81","author":"M Phadke","year":"2020","unstructured":"Phadke M, Saunik S. COVID-19 treatment by repurposing drugs until the vaccine is in sight. Drug Dev Res. 2020;81(5):541\u20133.","journal-title":"Drug Dev Res"},{"issue":"2suppl","key":"9915_CR5","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1177\/0145561320953231","volume":"100","author":"S Torretta","year":"2021","unstructured":"Torretta S, Zuccotti G, Cristofaro V, Ettori J, Solimeno L, Battilocchi L, et al. Diagnosis of SARS-CoV-2 by RT-PCR using different sample sources: review of the literature. Ear Nose Throat J. 2021;100(2suppl):S131\u20138.","journal-title":"Ear Nose Throat J"},{"key":"9915_CR6","doi-asserted-by":"crossref","unstructured":"Hanson KE, Caliendo AM, Arias CA, Englund JA, Hayden MK, Lee MJ et al. Infectious Diseases Society of America guidelines on the diagnosis of coronavirus disease 2019 (COVID-19): serologic testing. Clin Infect Dis. 2020:ciaa1343.","DOI":"10.1093\/cid\/ciaa1343"},{"key":"9915_CR7","doi-asserted-by":"publisher","first-page":"110124","DOI":"10.1016\/j.mehy.2020.110124","volume":"143","author":"J Adeoye","year":"2020","unstructured":"Adeoye J, Thomson P. The double-edged sword\u2019\u2013an hypothesis for Covid-19-induced salivary biomarkers. Med Hypotheses. 2020;143:110124.","journal-title":"Med Hypotheses"},{"issue":"3","key":"9915_CR8","doi-asserted-by":"publisher","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","volume":"25","author":"VM Corman","year":"2020","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25(3):2000045.","journal-title":"Eurosurveillance"},{"issue":"9","key":"9915_CR9","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1007\/s00216-022-03918-7","volume":"414","author":"BC Dhar","year":"2022","unstructured":"Dhar BC. Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic. Anal Bioanal Chem. 2022;414(9):2903\u201334.","journal-title":"Anal Bioanal Chem"},{"issue":"11","key":"9915_CR10","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1002\/jmv.25996","volume":"92","author":"M Dram\u00e9","year":"2020","unstructured":"Dram\u00e9 M, Teguo MT, Proye E, Hequet F, Hentzien M, Kanagaratnam L, et al. Should RT-PCR be considered a gold standard in the diagnosis of Covid\u201019? J Med Virol. 2020;92(11):2312.","journal-title":"J Med Virol"},{"issue":"1","key":"9915_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43088-023-00342-3","volume":"12","author":"MH Shafie","year":"2023","unstructured":"Shafie MH, Antony Dass M, Ahmad Shaberi HS, Zafarina Z. Screening and confirmation tests for SARS-CoV-2: benefits and drawbacks. Beni-Suef Univ J Basic Appl Sci. 2023;12(1):1\u201314.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"1","key":"9915_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s42399-020-00655-9","volume":"3","author":"S Roy","year":"2021","unstructured":"Roy S. Physicians\u2019 dilemma of false-positive RT-PCR for COVID-19: a case report. SN Compr Clin Med. 2021;3(1):255\u20138.","journal-title":"SN Compr Clin Med"},{"issue":"12","key":"9915_CR13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S2213-2600(20)30453-7","volume":"8","author":"E Surkova","year":"2020","unstructured":"Surkova E, Nikolayevskyy V, Drobniewski F. False-positive COVID-19 results: hidden problems and costs. Lancet Respiratory Med. 2020;8(12):1167\u20138.","journal-title":"Lancet Respiratory Med"},{"issue":"3","key":"9915_CR14","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1097\/JOM.0000000000002138","volume":"63","author":"GD Braunstein","year":"2021","unstructured":"Braunstein GD, Schwartz L, Hymel P, Fielding J. False positive results with SARS-CoV-2 RT-PCR tests and how to evaluate a RT-PCR-positive test for the possibility of a false positive result. J Occup Environ Med. 2021;63(3):e159.","journal-title":"J Occup Environ Med"},{"issue":"12","key":"9915_CR15","doi-asserted-by":"publisher","first-page":"e0242958","DOI":"10.1371\/journal.pone.0242958","volume":"15","author":"I Arevalo-Rodriguez","year":"2020","unstructured":"Arevalo-Rodriguez I, Buitrago-Garcia D, Simancas-Racines D, Zambrano-Achig P, Del Campo R, Ciapponi A, et al. False-negative results of initial RT-PCR assays for COVID-19: a systematic review. PLoS ONE. 2020;15(12):e0242958.","journal-title":"PLoS ONE"},{"issue":"8","key":"9915_CR16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00203-022-03118-y","volume":"204","author":"S Grewal","year":"2022","unstructured":"Grewal S, Syed Gurcoo M, Sudhan Sharma S. Comparative analysis of specificity and sensitivity between Cobas 6800 system and SARS-CoV-2 rRT-PCR to detect COVID-19 infection in clinical samples. Arch Microbiol. 2022;204(8):502.","journal-title":"Arch Microbiol"},{"issue":"50","key":"9915_CR17","doi-asserted-by":"publisher","first-page":"2000568","DOI":"10.2807\/1560-7917.ES.2020.25.50.2000568","volume":"25","author":"PS Wikramaratna","year":"2020","unstructured":"Wikramaratna PS, Paton RS, Ghafari M, Louren\u00e7o J. Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR. Eurosurveillance. 2020;25(50):2000568.","journal-title":"Eurosurveillance"},{"issue":"5","key":"9915_CR18","doi-asserted-by":"publisher","first-page":"e0251661","DOI":"10.1371\/journal.pone.0251661","volume":"16","author":"E Kortela","year":"2021","unstructured":"Kortela E, Kirjavainen V, Ahava MJ, Jokiranta ST, But A, Lindahl A, et al. Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients. PLoS ONE. 2021;16(5):e0251661.","journal-title":"PLoS ONE"},{"key":"9915_CR19","doi-asserted-by":"crossref","unstructured":"Rong G, Zheng Y, Chen Y, Zhang Y, Zhu P, Sawan M. COVID-19 diagnostic methods and detection techniques. Encyclopedia Sens Biosens. 2023:17.","DOI":"10.1016\/B978-0-12-822548-6.00080-7"},{"issue":"2","key":"9915_CR20","doi-asserted-by":"publisher","first-page":"E79","DOI":"10.1148\/radiol.2020201237","volume":"296","author":"D Caruso","year":"2020","unstructured":"Caruso D, Zerunian M, Polici M, Pucciarelli F, Polidori T, Rucci C, et al. Chest CT features of COVID-19 in Rome, Italy. Radiology. 2020;296(2):E79\u201385.","journal-title":"Radiology"},{"key":"9915_CR21","doi-asserted-by":"publisher","first-page":"112349","DOI":"10.1016\/j.bios.2020.112349","volume":"165","author":"F Cui","year":"2020","unstructured":"Cui F, Zhou HS. Diagnostic methods and potential portable biosensors for coronavirus disease 2019. Biosens Bioelectron. 2020;165:112349.","journal-title":"Biosens Bioelectron"},{"key":"9915_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bjid.2020.04.003","volume":"24","author":"R Castro","year":"2020","unstructured":"Castro R, Luz PM, Wakimoto MD, Veloso VG, Grinsztejn B, Perazzo H. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil. Brazilian J Infect Dis. 2020;24:180\u20137.","journal-title":"Brazilian J Infect Dis"},{"issue":"2","key":"9915_CR23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/bib\/bbaa328","volume":"22","author":"FP Caruso","year":"2021","unstructured":"Caruso FP, Scala G, Cerulo L, Ceccarelli M. A review of COVID-19 biomarkers and drug targets: resources and tools. Brief Bioinform. 2021;22(2):701\u201313.","journal-title":"Brief Bioinform"},{"key":"9915_CR24","doi-asserted-by":"publisher","first-page":"104224","DOI":"10.1016\/j.mvr.2021.104224","volume":"138","author":"MJ Al-Farabi","year":"2021","unstructured":"Al-Farabi MJ, Nugraha RA, Marsudi BA, Azmi Y. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Microvasc Res. 2021;138:104224.","journal-title":"Microvasc Res"},{"key":"9915_CR25","doi-asserted-by":"publisher","first-page":"733657","DOI":"10.3389\/fmed.2021.733657","volume":"8","author":"S Taleb","year":"2021","unstructured":"Taleb S, Yassine HM, Benslimane FM, Smatti MK, Schuchardt S, Albagha O, et al. Predictive biomarkers of intensive care unit and mechanical ventilation duration in critically-ill coronavirus disease 2019 patients. Front Med. 2021;8:733657.","journal-title":"Front Med"},{"issue":"1","key":"9915_CR26","doi-asserted-by":"publisher","first-page":"14601","DOI":"10.1038\/s41598-021-94256-8","volume":"11","author":"J Yang","year":"2021","unstructured":"Yang J, Chen C, Chen W, Huang L, Fu Z, Ye K, et al. Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis. Sci Rep. 2021;11(1):14601.","journal-title":"Sci Rep"},{"issue":"4","key":"9915_CR27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respiratory Med. 2020;8(4):420\u20132.","journal-title":"Lancet Respiratory Med"},{"issue":"1","key":"9915_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/cdd.2014.112","volume":"22","author":"A Wilczynska","year":"2015","unstructured":"Wilczynska A, Bushell M. The complexity of miRNA-mediated repression. Cell Death Differ. 2015;22(1):22\u201333.","journal-title":"Cell Death Differ"},{"issue":"8","key":"9915_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics\u2014challenges and potential solutions. Nat Rev Drug Discovery. 2021;20(8):629\u201351.","journal-title":"Nat Rev Drug Discovery"},{"issue":"5","key":"9915_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri.2016.40","volume":"16","author":"A Mehta","year":"2016","unstructured":"Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol. 2016;16(5):279\u201394.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"9915_CR31","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.3390\/ijms24043574","volume":"24","author":"S Reyes-Long","year":"2023","unstructured":"Reyes-Long S, Cort\u00e9s-Altamirano JL, Bandala C, Avenda\u00f1o-Ortiz K, Bonilla-Jaime H, Bueno-Nava A, et al. Role of the MicroRNAs in the pathogenic mechanism of painful symptoms in long COVID: systematic review. Int J Mol Sci. 2023;24(4):3574.","journal-title":"Int J Mol Sci"},{"key":"9915_CR32","doi-asserted-by":"crossref","unstructured":"Ryu G, Shin H-W. SARS-CoV-2 infection of airway epithelial cells. Immune Netw. 2021;21(1).","DOI":"10.4110\/in.2021.21.e3"},{"issue":"3","key":"9915_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.7555\/JBR.35.20200154","volume":"35","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang J, Ge Y, Xu Y, Guo M, Mi K, et al. SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response. J Biomedical Res. 2021;35(3):216.","journal-title":"J Biomedical Res"},{"key":"9915_CR34","doi-asserted-by":"crossref","unstructured":"Houshmandfar S, Saeedi-Boroujeni A, Rashno M, Khodadadi A, Mahmoudian-Sani M-R. miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19. Naunyn-Schmiedeberg\u2019s archives of pharmacology. 2021:1\u20139.","DOI":"10.1007\/s00210-021-02163-6"},{"issue":"8","key":"9915_CR35","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.4103\/jfmpc.jfmpc_2283_21","volume":"11","author":"R Mittal","year":"2022","unstructured":"Mittal R, Chourasia N, Bharti VK, Singh S, Sarkar P, Agrawal A, et al. Blood-based biomarkers for diagnosis, prognosis, and severity prediction of COVID-19: opportunities and challenges. J Family Med Prim Care. 2022;11(8):4330\u201341.","journal-title":"J Family Med Prim Care"},{"issue":"1197","key":"9915_CR36","first-page":"1","volume":"11","author":"EK Leon Tribolet","year":"2020","unstructured":"Leon Tribolet EK, Cowled C, Bean AGD, Stewart CR, Dearnley M, Ryan J. Farr. MicroRNA biomarkers for infectious diseases: from Basic Research to Biosensing. Front Microbiol. 2020;11(1197):1\u201315.","journal-title":"Front Microbiol"},{"key":"9915_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fimmu.2017.00118","volume":"8","author":"CN Correia","year":"2017","unstructured":"Correia CN, Nalpas NC, McLoughlin KE, Browne JA, Gordon SV, MacHugh DE, et al. Circulating microRNAs as potential biomarkers of infectious disease. Front Immunol. 2017;8:118.","journal-title":"Front Immunol"},{"issue":"2","key":"9915_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/vaccines11020374","volume":"11","author":"VP Chavda","year":"2023","unstructured":"Chavda VP, Valu DD, Parikh PK, Tiwari N, Chhipa AS, Shukla S, et al. Conventional and novel diagnostic tools for the diagnosis of emerging SARS-CoV-2 variants. Vaccines. 2023;11(2):374.","journal-title":"Vaccines"},{"key":"9915_CR39","doi-asserted-by":"crossref","unstructured":"Srijyothi L, Ponne S, Prathama T, Ashok C, Baluchamy S. Roles of non-coding RNAs in transcriptional regulation. Volume 55. Transcriptional and Post-transcriptional regulation; 2018.","DOI":"10.5772\/intechopen.76125"},{"key":"9915_CR40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.trac.2019.07.001","volume":"117","author":"Y-M Wang","year":"2019","unstructured":"Wang Y-M, Trinh MP, Zheng Y, Guo K, Jimenez LA, Zhong W. Analysis of circulating non-coding RNAs in a non-invasive and cost-effective manner. TRAC Trends Anal Chem. 2019;117:242\u201362.","journal-title":"TRAC Trends Anal Chem"},{"issue":"14","key":"9915_CR41","doi-asserted-by":"publisher","first-page":"11679","DOI":"10.3390\/ijms241411679","volume":"24","author":"J Niderla-Bieli\u0144ska","year":"2023","unstructured":"Niderla-Bieli\u0144ska J, Jankowska-Steifer E, W\u0142odarski P. Non-coding RNAs and human diseases: current status and future perspectives. Int J Mol Sci. 2023;24(14):11679.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9915_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000529985","volume":"66","author":"A Khatami","year":"2023","unstructured":"Khatami A, Taghizadieh M, Sadri Nahand J, Karimzadeh M, Kiani SJ, Khanaliha K, et al. Evaluation of MicroRNA expression pattern (miR-28, miR-181a, miR-34a, and miR-31) in patients with COVID-19 admitted to ICU and Diabetic COVID-19 patients. Intervirology. 2023;66(1):63\u201376.","journal-title":"Intervirology"},{"issue":"1","key":"9915_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1080\/22221751.2022.2038021","volume":"11","author":"A Fernandez-Pato","year":"2022","unstructured":"Fernandez-Pato A, Virseda-Berdices A, Resino S, Ryan P, Martinez-Gonzalez O, Perez-Garcia F, et al. Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. Emerg Microbes Infect. 2022;11(1):676\u201388.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"9915_CR44","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1038\/s41598-023-30474-6","volume":"13","author":"HA Mohamed","year":"2023","unstructured":"Mohamed HA, Abdelkafy AE, Khairy RMM, Abdelraheim SR, Kamel BA, Marey H. MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression. Sci Rep. 2023;13(1):3531.","journal-title":"Sci Rep"},{"key":"9915_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.trsl.2021.05.004","volume":"236","author":"D de Gonzalo-Calvo","year":"2021","unstructured":"de Gonzalo-Calvo D, Benitez ID, Pinilla L, Carratala A, Moncusi-Moix A, Gort-Paniello C, et al. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl Res. 2021;236:147\u201359.","journal-title":"Transl Res"},{"issue":"6","key":"9915_CR46","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.nrl.2021.06.005","volume":"38","author":"R Keikha","year":"2023","unstructured":"Keikha R, Hashemi-Shahri SM, Jebali A. The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness. Neurologia. 2023;38(6):e41\u201351.","journal-title":"Neurologia"},{"key":"9915_CR47","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.","journal-title":"Int J Surg"},{"issue":"11","key":"9915_CR48","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.7326\/M21-2234","volume":"174","author":"B Yang","year":"2021","unstructured":"Yang B, Mallett S, Takwoingi Y, Davenport CF, Hyde CJ, Whiting PF, et al. QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies. Ann Intern Med. 2021;174(11):1592\u20139.","journal-title":"Ann Intern Med"},{"issue":"6","key":"9915_CR49","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3348\/kjr.2015.16.6.1188","volume":"16","author":"J Lee","year":"2015","unstructured":"Lee J, Kim KW, Choi SH, Huh J, Park SH. Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part II. Statistical methods of meta-analysis. Korean J Radiol. 2015;16(6):1188\u201396.","journal-title":"Korean J Radiol"},{"key":"9915_CR50","doi-asserted-by":"publisher","first-page":"105020","DOI":"10.1016\/j.meegid.2021.105020","volume":"94","author":"M Fayyad-Kazan","year":"2021","unstructured":"Fayyad-Kazan M, Makki R, Skafi N, El Homsi M, Hamade A, El Majzoub R, et al. Circulating miRNAs: potential diagnostic role for coronavirus disease 2019 (COVID-19). Infect Genet Evol. 2021;94:105020.","journal-title":"Infect Genet Evol"},{"key":"9915_CR51","doi-asserted-by":"crossref","unstructured":"Agwa SHA, Elghazaly H, Meteini MSE, Shawky SM, Ali M, Abd Elsamee AM et al. In Silico Identification and Clinical Validation of a Novel Long non-coding RNA\/mRNA\/miRNA Molecular Network for potential biomarkers for discriminating SARS CoV-2 infection severity. Cells. 2021;10(11).","DOI":"10.3390\/cells10113098"},{"key":"9915_CR52","doi-asserted-by":"publisher","first-page":"107641","DOI":"10.1016\/j.intimp.2021.107641","volume":"97","author":"T Donyavi","year":"2021","unstructured":"Donyavi T, Bokharaei-Salim F, Baghi HB, Khanaliha K, Alaei Janat-Makan M, Karimi B, et al. Acute and post-acute phase of COVID-19: analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. Int Immunopharmacol. 2021;97:107641.","journal-title":"Int Immunopharmacol"},{"key":"9915_CR53","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.2147\/IDR.S372420","volume":"15","author":"X Li","year":"2022","unstructured":"Li X, Wang Y, Zhou Q, Pan J, Xu J. Potential predictive value of miR-125b-5p, mir-155-5p and their target genes in the Course of COVID-19. Infect Drug Resist. 2022;15:4079\u201391.","journal-title":"Infect Drug Resist"},{"key":"9915_CR54","doi-asserted-by":"publisher","first-page":"968991","DOI":"10.3389\/fimmu.2022.968991","volume":"13","author":"A Giannella","year":"2022","unstructured":"Giannella A, Riccetti S, Sinigaglia A, Piubelli C, Razzaboni E, Di Battista P, et al. Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients. Front Immunol. 2022;13:968991.","journal-title":"Front Immunol"},{"issue":"1","key":"9915_CR55","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pathol.2021.09.006","volume":"54","author":"RA Haroun","year":"2022","unstructured":"Haroun RA, Osman WH, Amin RE, Hassan AK, Abo-Shanab WS, Eessa AM. Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection. Pathology. 2022;54(1):104\u201310.","journal-title":"Pathology"},{"key":"9915_CR56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.omtn.2022.06.006","volume":"29","author":"M Calderon-Dominguez","year":"2022","unstructured":"Calderon-Dominguez M, Trejo-Gutierrez E, Gonzalez-Rovira A, Beltran-Camacho L, Rojas-Torres M, Eslava-Alcon S, et al. Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients. Mol Ther Nucleic Acids. 2022;29:76\u201387.","journal-title":"Mol Ther Nucleic Acids"},{"key":"9915_CR57","first-page":"101562","volume":"36","author":"O Shaker","year":"2023","unstructured":"Shaker O, El Amir M, Elfatah YA, Elwi HM. Expression patterns of lncRNA MALAT-1 in SARS-COV-2 infection and its potential effect on disease severity via miR-200c-3p and SIRT1. Biochem Biophys Rep. 2023;36:101562.","journal-title":"Biochem Biophys Rep"},{"issue":"9","key":"9915_CR58","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.2174\/0929867330666230515144133","volume":"31","author":"G Ayeldeen","year":"2024","unstructured":"Ayeldeen G, Shaker OG, Amer E, Zaafan MA, Herzalla MR, Keshk MA, et al. The impact of lncRNA-GAS5\/miRNA-200\/ACE2 Molecular Pathway on the severity of COVID-19. Curr Med Chem. 2024;31(9):1142\u201351.","journal-title":"Curr Med Chem"},{"issue":"1","key":"9915_CR59","doi-asserted-by":"publisher","first-page":"13806","DOI":"10.1038\/s41598-023-40754-w","volume":"13","author":"AI Moatar","year":"2023","unstructured":"Moatar AI, Chis AR, Romanescu M, Ciordas PD, Nitusca D, Marian C, et al. Plasma mir-195-5p predicts the severity of Covid-19 in hospitalized patients. Sci Rep. 2023;13(1):13806.","journal-title":"Sci Rep"},{"issue":"4","key":"9915_CR60","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00251-023-01308-6","volume":"75","author":"NE Hassan","year":"2023","unstructured":"Hassan NE, Moselhy WA, Eldomany EB, Kholef EFM. Evaluation of miRNA-16-2-3P, miRNA-618 levels and their diagnostic and prognostic value in the regulation of immune response during SARS Cov-2 infection. Immunogenetics. 2023;75(4):403\u201310.","journal-title":"Immunogenetics"},{"key":"9915_CR61","doi-asserted-by":"crossref","unstructured":"Abed RM, Abdulmalek HW, Yaaqoob LA. The role of miRNA20a and miRNA320 in Iraqi patients with COVID-19: a case\u2013control study. Egypt J Med Hum Genet. 2023;24(1).","DOI":"10.1186\/s43042-023-00451-9"},{"key":"9915_CR62","doi-asserted-by":"crossref","unstructured":"Soltane R, Almulla N, Alasiri A, Elashmawy NF, Qumsani AT, Alshehrei FM et al. A comparative analysis of MicroRNA expression in mild, moderate, and severe COVID-19: insights from urine, serum, and Nasopharyngeal Samples. Biomolecules. 2023;13(12).","DOI":"10.3390\/biom13121681"},{"issue":"1","key":"9915_CR63","doi-asserted-by":"publisher","first-page":"9822","DOI":"10.1038\/s41598-023-36421-9","volume":"13","author":"MI Gonz\u00e1lez-Ram\u00edrez","year":"2023","unstructured":"Gonz\u00e1lez-Ram\u00edrez MI, Cardona YT, Agudelo MC, L\u00f3pez C, Florez-Acosta JJ, Agudelo-Gamboa S, et al. miRNAs signature as potential biomarkers for cervical precancerous lesions in human papillomavirus positive women. Sci Rep. 2023;13(1):9822.","journal-title":"Sci Rep"},{"issue":"10","key":"9915_CR64","doi-asserted-by":"publisher","first-page":"844","DOI":"10.5152\/tjg.2022.21183","volume":"33","author":"X Wu","year":"2022","unstructured":"Wu X, Wan R, Ren L, Yang Y, Ding Y, Wang W. Circulating microRNA panel as a diagnostic marker for hepatocellular carcinoma. Turkish J Gastroenterol. 2022;33(10):844.","journal-title":"Turkish J Gastroenterol"},{"issue":"15","key":"9915_CR65","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.3390\/cancers13153909","volume":"13","author":"KI Notarte","year":"2021","unstructured":"Notarte KI, Senanayake S, Macaranas I, Albano PM, Mundo L, Fennell E, et al. MicroRNA and other non-coding RNAs in Epstein\u2013Barr virus-associated cancers. Cancers. 2021;13(15):3909.","journal-title":"Cancers"},{"issue":"3","key":"9915_CR66","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s42452-020-2251-0","volume":"2","author":"K Hasham","year":"2020","unstructured":"Hasham K, Ahmed N, Zeshan B. Circulating microRNAs in oncogenic viral infections: potential diagnostic biomarkers. SN Appl Sci. 2020;2(3):442.","journal-title":"SN Appl Sci"},{"issue":"6","key":"9915_CR67","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/diagnostics13061091","volume":"13","author":"M Jankovic","year":"2023","unstructured":"Jankovic M, Nikolic D, Novakovic I, Petrovic B, Lackovic M, Santric-Milicevic M. miRNAs as a potential biomarker in the COVID-19 infection and complications Course, Severity, and Outcome. Diagnostics. 2023;13(6):1091.","journal-title":"Diagnostics"},{"issue":"18","key":"9915_CR68","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2217\/bmm-2021-0348","volume":"15","author":"MB Visacri","year":"2021","unstructured":"Visacri MB, Nicoletti AS, Pincinato EC, Loren P, Saavedra N, Saavedra K, et al. Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field. Biomark Med. 2021;15(18):1785\u201395.","journal-title":"Biomark Med"},{"issue":"4","key":"9915_CR69","doi-asserted-by":"publisher","first-page":"170019","DOI":"10.1098\/rsob.170019","volume":"7","author":"A Moszy\u0144ska","year":"2017","unstructured":"Moszy\u0144ska A, Gebert M, Collawn JF, Bartoszewski R. SNPs in microRNA target sites and their potential role in human disease. Open Biology. 2017;7(4):170019.","journal-title":"Open Biology"},{"issue":"4","key":"9915_CR70","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2217\/fvl-2020-0389","volume":"16","author":"M Fani","year":"2021","unstructured":"Fani M, Zandi M, Ebrahimi S, Soltani S, Abbasi S. The role of miRNAs in COVID-19 disease. Future Virol. 2021;16(4):301\u20136.","journal-title":"Future Virol"},{"issue":"13","key":"9915_CR71","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2217\/epi-2023-0179","volume":"15","author":"S Erg\u00fcn","year":"2023","unstructured":"Erg\u00fcn S, Sankaranarayanan R, Petrovi\u0107 N. Clinically informative microRNAs for SARS-CoV-2 infection. Epigenomics. 2023;15(13):705\u201316.","journal-title":"Epigenomics"},{"key":"9915_CR72","doi-asserted-by":"crossref","unstructured":"Ahmad W, Gull B, Baby J, Panicker NG, Khader TA, Akhlaq S et al. Differentially-regulated miRNAs in COVID\u201019: a systematic review. Rev Med Virol. 2023:e2449.","DOI":"10.1002\/rmv.2449"},{"issue":"5","key":"9915_CR73","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1515\/cclm-2022-1256","volume":"61","author":"P Schlattmann","year":"2023","unstructured":"Schlattmann P. Tutorial: statistical methods for the meta-analysis of diagnostic test accuracy studies. Clin Chem Lab Med (CCLM). 2023;61(5):777\u201394.","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"9915_CR74","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cct.2016.01.008","volume":"47","author":"CR Dormuth","year":"2016","unstructured":"Dormuth CR, Filion KB, Platt RW. Likelihood ratio meta-analysis: new motivation and approach for an old method. Contemp Clin Trials. 2016;47:259\u201365.","journal-title":"Contemp Clin Trials"},{"issue":"01","key":"9915_CR75","first-page":"090","volume":"14","author":"D Dhamnetiya","year":"2021","unstructured":"Dhamnetiya D, Jha RP, Shalini S, Bhattacharyya K. How to analyze the diagnostic performance of a New Test? Explained with illustrations. J Lab Physicians. 2021;14(01):090\u20138.","journal-title":"J Lab Physicians"},{"issue":"4","key":"9915_CR76","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","volume":"23","author":"\u015eK \u00c7orbac\u0131o\u011flu","year":"2023","unstructured":"\u00c7orbac\u0131o\u011flu \u015eK, Aksel G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value. Turkish J Emerg Med. 2023;23(4):195.","journal-title":"Turkish J Emerg Med"},{"issue":"9","key":"9915_CR77","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315\u20136.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"9915_CR78","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1177\/0962280215592269","volume":"26","author":"Y Takwoingi","year":"2017","unstructured":"Takwoingi Y, Guo B, Riley RD, Deeks JJ. Performance of methods for meta-analysis of diagnostic test accuracy with few studies or sparse data. Stat Methods Med Res. 2017;26(4):1896\u2013911.","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"9915_CR79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.11613\/BM.2021.010502","volume":"31","author":"CC Serdar","year":"2021","unstructured":"Serdar CC, Cihan M, Y\u00fccel D, Serdar MA. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochemia Med. 2021;31(1):27\u201353.","journal-title":"Biochemia Med"},{"key":"9915_CR80","doi-asserted-by":"crossref","unstructured":"Sotiriadis A, Papatheodorou S, Martins WP. Synthesizing evidence from diagnostic accuracy TEsts: the SEDATE guideline. Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2016;47(3):386\u201395.","DOI":"10.1002\/uog.15762"},{"key":"9915_CR81","doi-asserted-by":"crossref","unstructured":"Caraguel CG, Vanderstichel R. The two-step Fagan\u2019s nomogram: ad hoc interpretation of a diagnostic test result without calculation. BMJ Evidence-Based Med. 2013.","DOI":"10.1136\/eb-2013-101243"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09915-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:28:40Z","timestamp":1726752520000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09915-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9915"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09915-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1011"}}